Holderness Investments CO Novartis Ag Transaction History

Holderness Investments CO

$425 Million
Q1 2025

A detailed history of Holderness Investments CO transactions in Novartis Ag stock. As of the latest transaction made, Holderness Investments CO holds 11,382 shares of NVS stock, worth $1.32 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

11,382

Previous 11,006 3.42%

Holding current value

$1.32 Million

Previous $1.07 Million 18.5%

% of portfolio

0.3%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$97.14 - $115.57 $36,524 - $43,454	376 Added 3.42%	11,382 $1.27 Million
Q4 2024 Feb 11, 2025	BUY	$96.78 - $117.18 $37,937 - $45,934	392 Added 3.69%	11,006 $1.07 Million
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $83,418 - $95,019	786 Added 8.0%	10,614 $1.22 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $62,299 - $72,260	673 Added 7.35%	9,828 $1.05 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $11,908 - $13,558	-125 Reduced 1.35%	9,155 $885,000
Q3 2023 Nov 15, 2023	SELL	$94.73 - $105.13 $2,368 - $2,628	-25 Reduced 0.27%	9,280 $945,000
Q2 2023 Aug 15, 2023	BUY	$92.52 - $104.91 $28,681 - $32,522	310 Added 3.45%	9,305 $938,000
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $13,445 - $15,592	168 Added 1.9%	8,995 $827,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $5,666 - $6,939	75 Added 0.86%	8,827 $800,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $11,937 - $13,961	160 Added 1.86%	8,752 $665,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $179,479 - $208,968	-2,229 Reduced 20.6%	8,592 $726,000
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $34,126 - $38,604	426 Added 4.1%	10,821 $950,000
Q4 2021 Feb 09, 2022	BUY	$79.7 - $88.13 $32,119 - $35,516	403 Added 4.03%	10,395 $909,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $27,478 - $31,967	336 Added 3.48%	9,992 $817,000
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $113,369 - $125,219	1,330 Added 15.97%	9,656 $881,000
Q1 2021 May 11, 2021	BUY	$83.5 - $98.47 $1,586 - $1,870	19 Added 0.23%	8,326 $712,000
Q4 2020 Feb 05, 2021	SELL	$78.07 - $94.43 $10,149 - $12,275	-130 Reduced 1.54%	8,307 $784,000
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $255,415 - $287,511	3,156 Added 59.76%	8,437 $737,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $39,009 - $54,653	552 Added 11.67%	5,281 $435,000
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $9,580 - $10,557	-112 Reduced 2.31%	4,729 $411,000
Q2 2019 Aug 02, 2019	BUY	$75.4 - $92.8 $2,714 - $3,340	36 Added 0.75%	4,841 $442,000
Q1 2019 May 20, 2019	SELL	$75.32 - $86.15 $6,778 - $7,753	-90 Reduced 1.84%	4,805 $462,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $79,331 - $88,335	1,077 Added 28.21%	4,895 $420,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $52,480 - $60,705	784 Added 25.84%	3,818 $329,000
Q2 2018 Aug 16, 2018	BUY	$64.91 - $73.36 $8,438 - $9,536	130 Added 4.48%	3,034 $229,000
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $24,636 - $29,452	-350 Reduced 10.76%	2,904 $235,000
Q3 2017 Nov 09, 2017	BUY	$74.14 - $77.27 $241,251 - $251,436	3,254	3,254 $279,000

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.

Account

Holderness Investments CO Novartis Ag Transaction History